BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6244836)

  • 21. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V
    Neurochem Res; 1979 Dec; 4(6):681-7. PubMed ID: 232543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings].
    Saeed SA; Butt NM; Taylor WA
    Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 27. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 28. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of calcium on cyclic nucleotide phosphodiesterase in parathyroid tissue.
    Willgoss D; Jacobi JM; de Jersey J; Bartley PC; Lloyd HM
    Biochem Biophys Res Commun; 1980 Jun; 94(3):763-8. PubMed ID: 6249291
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
    Crimaldi AA; Kuo IC; Coffee CJ
    Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
    Miot F; Erneux C
    Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of cyclic nucleotide phosphodiesterase by products of phosphatidylinositol metabolism catalyzed by phospholipase A2.
    Tai HH; Tai CL
    Arch Biochem Biophys; 1982 Apr; 214(2):622-7. PubMed ID: 6284032
    [No Abstract]   [Full Text] [Related]  

  • 33. Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells.
    Laasberg T; Pihlak A; Neuman T; Paves H; Saarma M
    FEBS Lett; 1988 Nov; 239(2):367-70. PubMed ID: 2460374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic nucleotide changes in X-irradiated synchronized Tetrahymena.
    Charp PA; Whitson GL
    Radiat Res; 1978 May; 74(2):323-34. PubMed ID: 208095
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
    Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
    Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal medullary cyclic nucleotide phosphodiesterase.--Regulatory properties of three enzyme activities.
    Sitaramayya A; Campbell JA; Siegel FL
    J Neurochem; 1978 Jun; 30(6):1281-5. PubMed ID: 209131
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclic nucleotides and cyclic nucleotide phosphodiesterase during development of Polysphondylium violaceum.
    Hanna MH; Klein C; Cox E
    Exp Cell Res; 1979 Sep; 122(2):265-71. PubMed ID: 228950
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition by purine compounds of cyclic GMP-stimulated cyclic AMP phosphodiesterase activity from a particulate fraction of rat striatum.
    Oleshansky MA
    Life Sci; 1980 Sep; 27(12):1089-95. PubMed ID: 6158640
    [No Abstract]   [Full Text] [Related]  

  • 40. 3':5'-cyclic-nucleotide phosphodiesterase in the bovine pituitary gland.
    Nagasaka A; Ohkubo S; Hidaka H
    Biochim Biophys Acta; 1983 Feb; 755(3):481-7. PubMed ID: 6297613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.